KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biogen (BIIB) Free Cash Flow (2016 - 2026)

Biogen has reported Free Cash Flow over the past 18 years, most recently at $594.3 million for Q1 2026.

For Q1 2026, Free Cash Flow rose 167.46% year-over-year to $594.3 million; the TTM value through Mar 2026 reached $2.4 billion, down 0.57%, while the annual FY2025 figure was $2.1 billion, 24.65% down from the prior year.
Free Cash Flow for Q1 2026 was $594.3 million at Biogen, up from $468.0 million in the prior quarter.
Over five years, Free Cash Flow peaked at $1.2 billion in Q3 2025 and troughed at -$261.4 million in Q4 2022.
A 5-year average of $457.7 million and a median of $507.3 million in 2024 define the central range for Free Cash Flow.
Biggest five-year swings in Free Cash Flow: plummeted 133.23% in 2022 and later skyrocketed 1469.26% in 2024.
Year by year, Free Cash Flow stood at -$261.4 million in 2022, then soared by 79.84% to -$52.7 million in 2023, then skyrocketed by 1469.26% to $721.6 million in 2024, then tumbled by 35.14% to $468.0 million in 2025, then rose by 26.99% to $594.3 million in 2026.
Business Quant data shows Free Cash Flow for BIIB at $594.3 million in Q1 2026, $468.0 million in Q4 2025, and $1.2 billion in Q3 2025.